Drug Trial Radar · NCT00439374
RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix
Last checked: Nov 19, 2026Latest source record: Jul 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
657
Actual
Start
Apr 2007
Primary completion
May 2011
Study completion Dec 2011
Sponsor
- Lead sponsor
- The George Washington University Biostatistics CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- First posted
- Feb 23, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Prevention
- Who can join
- Female only
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to see if giving progesterone medication to pregnant women, who have never delivered a baby after 19 weeks of pregnancy and who have a short cervix, lowers the risk of early delivery and improves the health of their baby.
Conditions
- Preterm Delivery
- Cervical Length
Interventions
17 alpha-hydroxyprogesterone caproateDrug
Coded study medication is sterile solution containing 250 mg/mL of 17 alpha-hydroxyprogesterone caproate in castor oil with benzyl benzoate and benzyl alcohol as a preservative; placebo is same without the active ingredient. Study drug is administered as weekly 1 ml intramuscular injections until 36 week 6 days of gestation or delivery, whichever occurs first.
Placebo OilOther
Placebo oil is a 250 mg/mL solution of castor oil with benzyl benzoate and benzyl alcohol as a preservative
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Delivering Before 37 Weeks GestationTime frame: Delivery before 37 weeks gestation
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama - Birmingham
Birmingham, Alabama
Northwestern University-Prentice Hospital
Chicago, Illinois
Dept of OB/GYN, Hutzel Hospital
Detroit, Michigan
Columbia University-St. Luke's Hospital
New York, New York
University of North Carolina - Chapel Hill
Chapel Hill, North Carolina
Case Western Reserve-Metrohealth
Cleveland, Ohio
Ohio State University Hospital
Columbus, Ohio
Oregon Health & Sciences University
Portland, Oregon
University of Pittsburgh-Magee Womens Hospital
Pittsburgh, Pennsylvania
Brown University -Women and Infants Hospital
Providence, Rhode Island
Dept of OB/GYN, Southwestern Medical Center, University of Texas
Dallas, Texas
University of Texas Medical Branch - Galveston
Galveston, Texas
University of Texas-Houston
Houston, Texas
University of Utah Medical Center
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.